How many investments has Solas BioVentures made?

Solas BioVentures has 31 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.

What stage does Solas BioVentures invest at?

Solas BioVentures invests at the Pre-Seed, Seed, Series A, Series B stages.

What sectors does Solas BioVentures focus on?

Solas BioVentures focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is Solas BioVentures located?

Solas BioVentures is headquartered in Chattanooga, US.

Does Solas BioVentures lead rounds?

Solas BioVentures has led 3 of the 7 rounds where its role is on record.

Who does Solas BioVentures co-invest with?

Solas BioVentures most often shares deals with Broadview Ventures, Rex Health Ventures, Arboretum Ventures, among 30 tracked co-investors.

What size deals does Solas BioVentures back?

Across 5 deals with disclosed amounts, Solas BioVentures has joined rounds of $1.5M – $55M (median $16M).

Solas BioVentures

Venture capital

Chattanooga · Pre-Seed–Series B · 17 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Solas BioVentures

678 people in our graph share verified history with the Solas BioVentures team — schools, employers, funds. One of them is your warm intro.

Sam Kingunlockedknows Mark Hackett · together at Tulane University

×3knows the team · via University of Tennessee, Knoxville

×2knows the team · via Tulane University

×2knows the team · via University of North Carolina Wilmington

×2knows the team · via Boston Medical Center (BMC)

knows the team · via WakeMed

✨ Fox Verdict

Investment thesis

Solas BioVentures invests exclusively in the life science industry, focusing on early-stage biopharmaceuticals, medical devices, and digital health. The firm takes a founder-centric approach aimed at enabling breakthrough medicine and meaningful technological innovation. Its investment team brings together expertise across medicine, biotechnology, operations, and finance, supported by a network of limited partners who add domain knowledge when evaluating opportunities. The firm frames its work at the intersection of medicine, science, and finance, backing founders it describes as visionaries, contrarians, entrepreneurs, doctors, scientists, lawyers, and financiers who aim to transform the standard of care and improve patient outcomes.

Invests inBiotech Digital Health Healthtech Medical Devices Chattanooga Global United States

Source: firm website, verified Sep 15, 2026.

Stage

Pre-Seed–Series B

Chattanooga, Tennessee, US

Instruments

Equity

Founded

2015

Last 12 months

1 investment

AUM

$165M

Tracked investments

IPOs

Team · 17 people

from the firm's website & curated & public directories

Michael Hoey· Co-Founder & Advisor· Greater Minneapolis-St. Paul Areain

Michael Hoey is the founder, board director, and chief technology officer of Francis Medical, a company developing water vapor therapy for the treatment of prostate cancer. He has founded 12 startup companies, seven of which have been acquired, including NxThera and Vessix Vascular by Boston Scientific, Salient Surgical by Medtronic, and Aegea Medical by Cooper Surgical, and he holds over 150 granted U.S. patents, primarily in the medical device field. Hoey is a general partner at Solas BioVentures, previously held faculty positions at the University of Minnesota and Hamline University, and serves on the boards of Frontline Medical and Morari Medical.

Charles David Adair· General Partner

Mark Hackett· Co-Founder & Partner· Chattanooga, Tennessee, United Statesin

m•••@solasbio.comreveal

Scott Kaplanis· Managing Partner & Co-Founder· Toronto, Ontario, Canadain

Scott Kaplanis is a Partner at Groundbreak Ventures, where he invests in early-stage innovation companies. He has nearly 20 years of capital markets experience spanning origination and asset management, and works with entrepreneurs as both an investor and adviser.

s•••@groundbreakventures.comreveal

David Adair· Managing Director· Greater Chattanoogain

David Adair is a co-founder and Managing Director of Solas BioVentures, having worked with the firm's partners since 2004 and become a founding member in 2014. He focuses on investments in medical device and therapeutic companies, drawing on nearly 20 years as a physician, educator, administrator, and biotech/med-tech investor. He is board certified in Maternal-Fetal Medicine, Obstetrics and Gynecology, and Hypertension, with expertise in Critical Care.

d•••@solasbio.comreveal

Joshua Eckelberry· Partner· Chattanooga, Tennessee, United Statesin

Joshua Eckelberry is a Partner at Solas BioVentures, where he focuses on healthcare innovation. He holds a Bachelor of Science in Biochemistry from East Tennessee State University and an MBA in Healthcare Administration, and attended the Quillen College of Medicine. His background combines scientific, operational, and healthcare strategy experience.

j•••@solasbio.comreveal

Travis Manasco· Partner· Raleigh, NCin

Travis Manasco is a physician and healthcare investor who earned his medical degree from Tulane University School of Medicine, completed an Emergency Medicine residency at Boston Medical Center, and a Critical Care Medicine fellowship at Washington University in St. Louis. He holds board certifications in Emergency Medicine, Critical Care, and Neurocritical Care. He co-founded Bio54, where he served as Chief Medical Officer, is a Partner at Solas BioVentures, and continues to practice in the ICU at WakeMed Health and Hospitals.

t•••@solasbio.comreveal

David Belitz· Partner at Solas Bioventures· Chattanooga, Tennessee, United Statesin

d•••@chattanoogarenaissancefund.comreveal

Julian Duniec· Managing Directorin

Tech partner focused on technology and engineering.

ConnieLynn Hutchison· Office Manager· Chattanooga, Tennessee, United Statesin

ConnieLynn Hutchison is an Administrative Assistant at Solas BioVentures with a background as a full-charge bookkeeper across multiple industries, handling tasks such as accounts payable and receivable, payroll, financial reporting, and 1099/W2 preparation. Her technical skills include QuickBooks, Quicken, MS Excel, ADP, and Paychex. She also has experience as a personal chef in the restaurant industry and completed culinary training focused on Italian studies at the International Culinary Center.

Emma Heckenberg· Analyst· Durham, North Carolina, United Statesin

Emma Heckenberg is an analyst at Solas BioVentures, focusing on healthcare companies. She holds a Ph.D. in Molecular Genetics and Microbiology from Duke University, where her research examined the impact of viral infections on pediatric populations, and a B.S. in Biology with a minor in Business from Drexel University.

Isaiah Reeves· Analyst· Greater Chattanoogain

Isaiah Reeves is a Senior Analyst at Solas BioVentures in Chattanooga, Tennessee. He earned a PhD from the St. Jude Children's Research Hospital Graduate School of Biomedical Sciences, where he studied under Dr. Andrew Davidoff, and holds a B.S. in Biological Sciences with a concentration in Biochemistry, Cellular, and Molecular Biology from the University of Tennessee. He has more than eight years of research experience.

Julia Ray· Controller· Greater Chattanoogain

Laurent Pacheco· Advisorin

Michael Ackermann· Advisor· Chapel Hill, North Carolina, United Statesin

Michael Ackermann is Managing Director at Solas BioVentures and a co-founder, board member, and Chief Business Officer at Arrivo BioVentures LLC. He has more than thirty years of experience in global life sciences, including roles at Eli Lilly and Quintiles (IQVIA), with work spanning strategy and implementation and responsibility for P&L of up to $4.3 billion. He holds a Ph.D. in immunology from Drexel Medical College, completed a Fogarty Fellowship at NIH, and earned an MBA from the University of North Carolina's Kenan-Flagler Business School, along with executive education at Harvard.

Lana Caron· Advisor

Caron previously led digital health and health tech partnerships and investments at Philips Ventures, the venture arm of Philips. She has held leadership roles at health technology startups covering sales, marketing, and business development, and earlier worked as Director of Corporate Development at a technology company spun off from Texas Instruments and as Manager of Strategy & Business Development at a division of Philips Healthcare, handling deals valued between $15M and $200M.

l•••@solasbio.comreveal

Casey Hammontree· Advisor· Chattanooga, Tennesseein 𝕏

Partner, Chief Operations Officer and Chief Compliance Officer leading the firm's operational, financial and regulatory functions. A founding member of Fund III, he previously worked at Wellington Management, Joseph Decosimo and Company, and Tenth Street Capital. He holds an MBA from UNC Chapel Hill, a Masters in Biotechnology Enterprise from Johns Hopkins, a BBA from East Tennessee State, and is a CFA charterholder.

c•••@resolutecap.comreveal

Founder mafia

4 people who came through Solas BioVentures went on to found or lead other companies.

Michael HoeyCo-Founder & AdvisorFounded Uptake Medical +1 Michael AckermannAdvisorFounded Arrivobio Casey HammontreeAdvisorFounded Motionwear Mark ChristophersonEntrepreneur In ResidenceFounded Lunair Medical

What they invest in

from 28 of 31 portfolio companies

Healthtech ×24Medical Devices ×20Biotech ×15Digital Health ×10Hardware ×6AI & Machine Learning ×5Deep Tech ×3FemTech ×2

HQs:United States×21

Who they back

founder profiles across 13 portfolio companies

54%

solo founders

7 of 13 mapped founding teams

~4 yrs

old at investment

median across 8 dated deals

Founding team size:solo founder×72 founders×54+ founders×1

Investments · 31 tracked

founders shown can be your intro path

By year:2026 · 1 2024 · 1 2023 · 1 2022 · 4 2021 · 6 2020 · 2 2019 · 116 dated

Shionogishionogi.comOTC: SGIOF

Shionogi is a pharmaceutical company that discovers and develops medicines for challenging human diseases, including antibiotics and treatments for HIV, influenza, and COVID-19.

BiotechHealthtech

Co-investorsAdvent Life Sciences

Tvardi Therapeuticstvarditherapeutics.com in 𝕏NASDAQ: TVRDJun 2021

Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases.

BiotechHealthtechHouston, US

David J. Tweardy(Executive Officer, Director)Imran Alibhai(Chief Executive Officer)inRonald DePinho(Director)Josef Schoell(Executive Officer)Jeffrey L. Ives(Director)Joseph W. Stauffer(Executive Officer)

Co-investorsShangBay Capital LLC

Stimdia Medicalstimdia.com in 𝕏Series B · Jul 2022 · $16M✓ verified

Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.

BiotechDeep TechHealthtechMedical DevicesEdina, US

Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)inJim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)inAllen Meacham(President and Chief Executive Officer)inBrad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)in

Co-investorsFresenius Medical Care Ventures

Francis Medicalfrancismedical.com in 𝕏Series B · Sep 2021 · $55M

Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System.

BiotechDigital HealthHealthtechMedical DevicesMaple Grove, US

Michael Hoey(Founder)inMichael Kujak(Executive Officer, Director)Christopher Dixon(Chief Medical Officer)in

BoardAndrew Cleeland(Director)Jan Garfinkle(Director)inDavid Adair(Director)in

Board seat Michael Hoey· per SEC Form D

Co-investorsArboretum Ventures

Advanced Catheter Therapiesacatheter.com

Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation.

BiotechHealthtechMedical Devices

Paul J. Fitzpatrick(Chief Executive Officer)

Co-investorsChattanooga Renaissance Fund Innova Memphis, Inc.

Arctxmedicalarctxmedical.com in

Arctx Medical develops an investigational cooling therapy device designed to treat acute pancreatitis by reducing pancreatic inflammation through localized temperature control.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsScientific Health Development

Arrivobioarrivobio.com in

Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist.

BiotechMedical Devices

Co-investorsOrlando Health Ventures Rex Health Ventures

Aurenaraurenar.comJul 2026

Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients.

HardwareHealthtechMedical Devices

Eric Leuthardt(Chief Executive Officer & Founder)inJenna Gorlewicz(Chief Technology Officer & Founder)inAnna Huguenard(Chief Medical Officer & Founder)in Jesse Wheeler(Chief Operations Officer)in Ryan Kight(Chief Financial Officer)in

Co-investorsKaleida Capital Deep Future

Baebiesbaebies.com in 𝕏

Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.

BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US

Vamsee Pamula(Executive Officer, Director)in

BoardDennis Sacha(Director)William A. Hawkins(Director)

Co-investorsDuke Capital Partners IAG Capital Partners Rex Health Ventures VentureSouth

Basking Biosciencesbaskingbiosciences.com inAug 2020 · $55M

Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.

BiotechDigital HealthHealthtechMedical DevicesCary, US

Shahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)Julia Owens(Executive Officer, Director, Promoter)in Richard Shea(Executive Officer, Director, Promoter)in

BoardHannah Chang(Director)Aiden Aceves(Director)in

Co-investorsARCH Venture Partners Insight Partners Broadview Ventures Rev1 Ventures RTW Investments L.P.

CardioNXTcardionxt.comMar 2019

CardioNXT develops cardiac mapping and navigation technology, including its iMap System, used to navigate next-generation pulsed field ablation (PFA) catheters for cardiac procedures such as pulmonary vein isolation and left atrium mapping.

HardwareHealthtechMedical DevicesWestminster, US

Donald Conty(Executive Officer, Director, Promoter)Jerome Edwards(Executive Officer, Director, Promoter)

BoardThomas Kurian(Director, Promoter)

Corcymcorcym.com in 𝕏

Corcym is a medical device company that develops therapies and devices for patient care.

HardwareHealthtechMedical Devices

Co-investorsB Capital

CryOSAcryosa.comSeries B · Sep 2021 · $22M

Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways.

BiotechHealthtechMedical DevicesArden Hills, US

Laura Stoltenberg(Executive Officer, Director)in

Board David Belitz(Director)inDoug French(Director)James Eadie(Director)Donald Gonzales(Founder and Chief Medical Officer)

Co-investorsBrightstone Venture Capital

Dimension Inxdimensioninx.com in

Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging.

BiotechHealthtechNew MaterialsChicago, US

Caralynn Nowinski Collens, M.D.(Co-founder & CEO)inRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)in Adam Jakus(Executive Officer, Director)in

BoardRima Chakrabarti(Director)in

Co-investorsBetter Ventures Central Llc Lofty Ventures Pathway Bioventures Portal Innovations KdT Ventures Prime Movers Lab

EirSystemseirsystems.netSeed · Aug 2022 · $1.5M

EirSystems builds medication management infrastructure for healthcare providers and EHR platforms, focusing on electronic medication administration records and opioid prescription monitoring across long-term care, behavioral health, and post-acute settings.

Digital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSChattanooga, US

Robert Newman(Executive Officer, Director, Promoter)inRyan Seaberg(Co-Founder)Tyler Seaberg(Executive Officer, Director, Promoter)

Co-investorsAtlanta Technology Angels Chain Reaction

I-O Urologyi-ourology.com

Develops an at-home device that measures bladder and urinary symptoms in men and generates a report for healthcare providers to support clinical decisions.

Digital HealthHardwareMedical DevicesKnoxville, US

Ryan Wilemsen(Executive Officer)Stephen Grady Arnold(Executive Officer)Britton Alan Garrett(Executive Officer, Director)John Green(Executive Officer)Brent Laing(Executive Officer, Director)Brad Rouse(Director)

Co-investorsJumpstart Capital

Intershuntintershunt.com inJan 2021 · $3M

Intershunt develops the Dynama System (also known as the PAS-C System), an investigational interatrial shunting device designed to create a pathway in the heart's upper chambers to reduce elevated left atrial pressure and relieve heart failure symptoms.

HardwareHealthtechMedical DevicesFridley, US

Harlan Lee Sorkin(Executive Officer, Director)Gil M. Vardi(Director)

BoardDenis Harrington(Director)inDavid Adair(Director)inJim Bullock(Director)

Ischemia Careischemiacare.com

Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes.

AI & Machine LearningDigital HealthHealthtechMedical DevicesOxford, US

Jeffrey June(Executive Officer, Director)Teresa June(Executive Officer)in

Co-investorsBroadview Ventures Early Stage Partners, LP

Jazz Pharmaceuticaljazzpharma.com in 𝕏

Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.

BiotechHealthtech

Co-investorsLongitude Capital Prospect Venture Partners Rex Health Ventures

Knoppbioknoppbio.comSeries C · Nov 2020 · $14M

Knopp Biosciences is a privately held company that manages a portfolio of future milestone payments and product royalties from drug pipelines it sold or spun off in 2022.

BiotechHealthtechPittsburgh, US

Thomas V. Petzinger, Jr.(LLC Manager)Michael E. Bozik(LLC Manager)Steven Dworetzky(Executive Officer)

BoardBenjamin A. Gomez(LLC Manager)Jeffrey S. McCormick(LLC Manager)inGregory T. Hebrank(LLC Manager)

Co-investorsSaturn Partners

NX Prenatalnxprenatal.com

NX Prenatal is a molecular diagnostics company developing exosome-based liquid biopsy assays that detect adverse pregnancy conditions such as preterm birth, preeclampsia, and placenta accreta.

BiotechDigital HealthFemTechHealthtechLouisville, US

Paul Kortschak(Chief Executive Officer)GAIL PAGE(Executive Officer, Director)BRIAN BROHMAN(Executive Officer, Director)ROBERT SAUNDERS(Director)KEVIN BRAMER(Director)ALAN MACK(Director)

Co-investorsBelle Impact Fund Mindshift Capital Golden Seeds Portfolia

Olympusamericaolympusamerica.com

Olympus develops medical technologies and solutions for detecting and treating disease.

HardwareHealthtechMedical Devices

Pathwarepathware.com inApr 2022 · $7M

Pathware provides real-time biopsy quality assessment technology for pathologists to determine sample adequacy on-site, reducing repeat procedures and unnecessary surgeries.

AI & Machine LearningHealthtechMedical Devices

Co-investorsCANTILEVER INVESTORS Innoventures Iowa Next Level Ventures Level Eight Ventures

Phenomics Healthphenomicshealth.com inOct 2022

Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions.

AI & Machine LearningDigital HealthHealthtechPlymouth, US

Brian D. Athey(Co-founder)Daniel Jasewicz(Company Leadership (Strategy & Commercialization))in Gerry Higgins(Scientific Strategy Lead)in Alex Ade(Technology & Data Science Lead)inPamela Weir(Director)Lew Wallace(Director)

Pretelhealthpretelhealth.com

PreTel develops wearable uterine electromyography sensors and AI-powered analysis software to monitor uterine contractions during pregnancy, enabling early detection of preterm labor, assessment of false labor, and guided Pitocin dosing during labor induction for obstetric care providers.

AI & Machine LearningFemTechMedical DevicesChattanooga, US

Roger Young(Chief Medical Officer / Founder)Marc Finch(CEO)

BoardMark A Samuels(Chairman)

Co-investorsTech Square Ventures

Vektor Medicalvektormedical.com inSeries A · Feb 2024 · $16M

Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias.

AI & Machine LearningDigital HealthHealthtechMedical DevicesCarlsbad, US

Chris Villongco(Head of Technology / CTO)in Rob Krummen(CEO (formerly President & COO))inKelly Perez(Head of Finance)inAlexander Michael Monko(Executive Officer, Director)

Co-investorsTVM Capital Life Science

Vesaliovesalio.com in 𝕏Jul 2021

Vesalio develops stroke treatment technology, specifically devices and systems for endovascular neurosurgical interventions to treat acute ischemic and hemorrhagic stroke.

Deep TechHealthtechMedical Devices

Arthur J. Ulm(CTO/Founder/Board Member)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Bio 54, LLCAegeamedicalArrivo BioVenturesRediscoveryls

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 2

2 IPOs

ShionogiOTC: SGIOFTvardi TherapeuticsNASDAQ: TVRD

Portfolio news

latest coverage across their companies

Tvardi management will participate in three investor events in September

Tvardi Therapeutics · stocktitan.net · Aug 26, 2026

St. Louis startups secure millions in latest bioscience funding rounds | St. Louis Magazine

Aurenar · stlmag.com · Aug 19, 2026

【Shionogi (4507.T) FY2026 Q1 Earnings Call】Revenue Hits Record ¥163.3 Billion, All Profit Lines at All-Time Highs — ViiV Equity Method and U.S. Business Drive Growth, PPA Incomplete Raises Questions on Zero Amortization Disclosure — BigGo Finance

Shionogi · finance.biggo.com · Aug 4, 2026

Basking Biosciences | Investment | Insight Partners

Basking Biosciences · insightpartners.com · Jan 21, 2026

Sell or Invest in Vektor Medical Stock Pre-IPO

Vektor Medical · nasdaqprivatemarket.com · Nov 20, 2025

IEDA Board approves assistance for six established companies, three startups and six community quality of life projects | Economic Development & Finance Authority

Pathware · opportunityiowa.gov · Sep 19, 2025

Frequently asked questions

How many investments has Solas BioVentures made?: Solas BioVentures has 31 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
What stage does Solas BioVentures invest at?: Solas BioVentures invests at the Pre-Seed, Seed, Series A, Series B stages.
What sectors does Solas BioVentures focus on?: Solas BioVentures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Solas BioVentures located?: Solas BioVentures is headquartered in Chattanooga, US.
Does Solas BioVentures lead rounds?: Solas BioVentures has led 3 of the 7 rounds where its role is on record.
Who does Solas BioVentures co-invest with?: Solas BioVentures most often shares deals with Broadview Ventures, Rex Health Ventures, Arboretum Ventures, among 30 tracked co-investors.
What size deals does Solas BioVentures back?: Across 5 deals with disclosed amounts, Solas BioVentures has joined rounds of $1.5M – $55M (median $16M).

Images

Co-investors · 1

Arboretum Ventures

Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.

Both backed · 1

Francis Medical

$5M – $15M

Firms observed investing alongside Solas BioVentures, from public investor directories. Shared companies are the overlap with Solas BioVentures's recorded portfolio.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Innovestor Ventures

Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.

$270K – $3.2M